{"DataElement":{"publicId":"3527996","version":"1","preferredName":"New Tumor Prior To Resection Radiologic Depth Value","preferredDefinition":"Numeric value for the depth of the new tumor reported on the computed tomography or magnetic resonance imaging immediately preceding the surgical resection.","longName":"3527927v1.0:3527937v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3527927","version":"1","preferredName":"New Tumor Prior To Resection Radiologic Depth","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Earlier in time or order._Used as a function word to indicate direction, purpose, or movement._The act of cutting out; the surgical removal of part or all of a structure or organ._The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease._The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness.","longName":"3108264v1.0:3527906v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3108264","version":"1","preferredName":"New Neoplasm","preferredDefinition":"New; having no previous example or precedent or parallel.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C25586:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8883C12C-4F39-5E58-E040-BB89AD437DB2","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3527906","version":"1","preferredName":"Prior To Excision Radiology Depth","preferredDefinition":"Earlier in time or order.:Used as a function word to indicate direction, purpose, or movement.:The act of cutting out; the surgical removal of part or all of a structure or organ. :The use of radiation (such as x-rays) or other imaging technologies (such as ultrasound and magnetic resonance imaging) to diagnose or treat disease.:Depth; extent downward or inward.","longName":"3527906v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Excision","conceptCode":"C15232","definition":"The surgical removal of a lesion, often as part of a biopsy and with healthy margins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Radiology","conceptCode":"C17059","definition":"The branch of medical science dealing with the medical use of X-rays or other penetrating radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Depth","conceptCode":"C25333","definition":"The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5287A-9511-620B-E040-BB89AD43614B","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"ONEDATA","dateModified":"2012-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5B496-FDE4-E567-E040-BB89AD432C45","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by T.Lichtenberg. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3527937","version":"1","preferredName":"Tumor Measurement Value","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard._A numerical quantity measured or assigned or computed.","longName":"3527937v1.0","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"cm","minLength":"6","maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3527936","version":"1","preferredName":"Neoplasm Measurement Value","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.:A numerical quantity measured or assigned or computed.","longName":"C3262:C25209:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5B496-FE74-E567-E040-BB89AD432C45","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"ONEDATA","dateModified":"2012-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F5B496-FE85-E567-E040-BB89AD432C45","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"COOPERM","dateModified":"2012-07-24","changeDescription":"Created for TCGA per request by T.Lichtenberg. mc 7/16/12 Released per approval 7/24/12 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"}]}],"AlternateNames":[{"name":"radiologic_tumor_depth","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Radiologic Depth of New Tumor","type":"Preferred Question Text","description":"Radiologic Depth of New Tumor","url":null,"context":"NCIP"},{"name":"TCGA Form Instruction","type":"COMMENT","description":"This should include both well-differentiated and de-differentiated components.","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C4F7A060-F0D1-28BE-E040-BB89AD43526E","latestVersionIndicator":"Yes","beginDate":"2012-07-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-16","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Released per approval by T.Lichtenberg. mc 7/24/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}